These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36799476)

  • 1. Characterization of high-molecular weight by-products in the production of a trivalent bispecific 2+1 heterodimeric antibody.
    Cramer DAT; Franc V; Heidenreich AK; Hook M; Adibzadeh M; Reusch D; Heck AJR; Haberger M
    MAbs; 2023; 15(1):2175312. PubMed ID: 36799476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-Column Denaturation-Assisted Native Size-Exclusion Chromatography-Mass Spectrometry for Rapid and In-Depth Characterization of High Molecular Weight Variants in Therapeutic Monoclonal Antibodies.
    Yan Y; Xing T; Liu AP; Zhang Z; Wang S; Li N
    J Am Soc Mass Spectrom; 2021 Dec; 32(12):2885-2894. PubMed ID: 34786946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid characterization of biotherapeutic proteins by size-exclusion chromatography coupled to native mass spectrometry.
    Haberger M; Leiss M; Heidenreich AK; Pester O; Hafenmair G; Hook M; Bonnington L; Wegele H; Haindl M; Reusch D; Bulau P
    MAbs; 2016; 8(2):331-9. PubMed ID: 26655595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling the mysteries of modern size exclusion chromatography - the way to achieve confident characterization of therapeutic proteins.
    Goyon A; Fekete S; Beck A; Veuthey JL; Guillarme D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():368-378. PubMed ID: 29936373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyphenation of size exclusion chromatography to native ion mobility mass spectrometry for the analytical characterization of therapeutic antibodies and related products.
    Ehkirch A; Hernandez-Alba O; Colas O; Beck A; Guillarme D; Cianférani S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1086():176-183. PubMed ID: 29684909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LC-MS characterization and purity assessment of a prototype bispecific antibody.
    Woods RJ; Xie MH; Von Kreudenstein TS; Ng GY; Dixit SB
    MAbs; 2013; 5(5):711-22. PubMed ID: 23884083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Bispecific Antibody Production in Cell Cultures by Unique Mixed Mode Size Exclusion Chromatography.
    Jiang H; Xu W; Liu R; Gupta B; Kilgore B; Du Z; Yang X
    Anal Chem; 2020 Jul; 92(13):9312-9321. PubMed ID: 32497423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells.
    Reusch U; Duell J; Ellwanger K; Herbrecht C; Knackmuss SH; Fucek I; Eser M; McAleese F; Molkenthin V; Gall FL; Topp M; Little M; Zhukovsky EA
    MAbs; 2015; 7(3):584-604. PubMed ID: 25875246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Multidimensional Liquid Chromatography-Mass Spectrometry for the Characterization of Charge Variants of a Bispecific Antibody.
    Grunert I; Heinrich K; Hingar M; Ernst J; Winter M; Bomans K; Wagner K; Fevre A; Reusch D; Wuhrer M; Bulau P
    J Am Soc Mass Spectrom; 2022 Dec; 33(12):2319-2327. PubMed ID: 36442848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coupling Mixed-Mode Size Exclusion Chromatography with Native Mass Spectrometry for Sensitive Detection and Quantitation of Homodimer Impurities in Bispecific IgG.
    Yan Y; Xing T; Wang S; Daly TJ; Li N
    Anal Chem; 2019 Sep; 91(17):11417-11424. PubMed ID: 31373790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD3 Target Affinity Chromatography Mass Spectrometry as a New Tool for Function-Structure Characterization of T-Cell Engaging Bispecific Antibody Proteoforms and Product-Related Variants.
    Lippold S; Hook M; Spick C; Knaupp A; Whang K; Ruperti F; Cadang L; Andersen N; Vogt A; Grote M; Reusch D; Haberger M; Yang F; Schlothauer T
    Anal Chem; 2023 Jan; 95(4):2260-2268. PubMed ID: 36638115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of monoclonal antibody dimers in a final formulated drug by separation techniques coupled to native mass spectrometry.
    Rouby G; Tran NT; Leblanc Y; Taverna M; Bihoreau N
    MAbs; 2020; 12(1):e1781743. PubMed ID: 32633190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bispecific antibody characterization by a combination of intact and site-specific/chain-specific LC/MS techniques.
    Duivelshof BL; Beck A; Guillarme D; D'Atri V
    Talanta; 2022 Jan; 236():122836. PubMed ID: 34635226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometry for quality control of bispecific antibodies after SDS-PAGE in-gel digestion.
    Hörner S; Ghosh M; Kauer J; Spät P; Rammensee HG; Jung G; Pflügler M
    Biotechnol Bioeng; 2021 Aug; 118(8):3069-3075. PubMed ID: 33988851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated Approach for Characterizing Bispecific Antibody/Antigens Complexes and Mapping Binding Epitopes with SEC/MALS, Native Mass Spectrometry, and Protein Footprinting.
    Huang RY; Wang F; Wheeler M; Wang Y; Langish R; Chau B; Dong J; Morishige W; Bezman N; Strop P; Rajpal A; Gudmundsson O; Chen G
    Anal Chem; 2020 Aug; 92(15):10709-10716. PubMed ID: 32639723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights from native mass spectrometry and ion mobility-mass spectrometry for antibody and antibody-based product characterization.
    Terral G; Beck A; Cianférani S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():79-90. PubMed ID: 27108304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated development of a SEC-HPLC procedure for purity analysis of monoclonal antibodies using design of experiments.
    Cernosek T; Jain N; Dalphin M; Behrens S; Wunderli P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Mar; 1235():124037. PubMed ID: 38335765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streamlining the polishing step development process via physicochemical characterization of monoclonal antibody aggregates.
    Doss HR; Raman M; Knihtila R; Chennamsetty N; Wang D; Shupe A; Mussa N
    J Chromatogr A; 2019 Aug; 1598():101-112. PubMed ID: 30954243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Size-exclusion chromatographic study of ECF and TCF softwood kraft pulp bleaching liquors.
    Kukkola J; Knuutinen J; Paasivirta J; Herve S; Pessala P; Schultz E
    Environ Sci Pollut Res Int; 2011 Aug; 18(7):1049-56. PubMed ID: 21717168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Culture temperature modulates half antibody and aggregate formation in a Chinese hamster ovary cell line expressing a bispecific antibody.
    Gomez N; Wieczorek A; Lu F; Bruno R; Diaz L; Agrawal NJ; Daris K
    Biotechnol Bioeng; 2018 Dec; 115(12):2930-2940. PubMed ID: 30036451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.